MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

In arguments that ranged from classic cars to Western omelets, key conservative justices seemed open to the government's argument that kits allowing people to make nearly untraceable guns at home can ...

Tempur-Pedic Bed Bases manufactures adjustable bed bases. The company's beds offer features like wireless remote controls, zero-gravity presets and lumbar support. Tempur-Pedic combines its adjustable ...